Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Polycythemia Vera 1Neoplasms 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphadenopathy 1HIV Infections 1

Interventions

Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2Etoposide 2Cyclophosphamide 2liposomal doxorubicin 1fludarabine 1dehydroftorafur 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1axicabtagene ciloleucel 1Zidovudine 1Vincristine 1Valganciclovir 1Standard of Care 1Smoking Devices 1Sirolimus 1Sigmoidoscopy 1Sentinel Lymph Node Biopsy 1Rituximab 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Proctoscopy 1Prednisone 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Mitozytrex 1Mitomycin 1Melphalan 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Interferon-alpha × 90 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡